Skip to content
Sign in
StableScienceReported 2026-11-19 05:20

Blood test may reveal which lymphoma patients will respond to immunotherapy

Cornell engineers and Dana-Farber oncologists found a blood test that can predict which lymphoma patients will respond to CAR T-cell therapy, a major breakthrough in treating large B-cell lymphoma.

Why it matters. This test could help doctors identify patients who are more likely to benefit from the therapy, improving treatment outcomes and reducing unnecessary treatments.

01

Who and what it touches

FUCASOusesIomab-ACTenablesGamma delta T cellsuseschimeric antigen rece…usesimmune T cellsusesModified immune cellsusesPatients' own immune …usesT cellsusesCAR T-cell ther…

Each line is a relation with evidence behind it, drawn in the direction it points. A line shows that two things are connected, not how far this change reaches.

02

Evidence

  • MMedical XpressMedia2026-11-19 05:20
    View source